EligibleTrials

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Recruiting · NCT07011043 · Interventional (participants receive a specific treatment) · Lead sponsor: Climb Bio, Inc.

View the official record on ClinicalTrials.gov →
Lupus

Interventions studied

Budoprutug

What this trial is about

The main objective is to assess the safety and tolerability of budoprutug in adults with SLE. Pharmacokinetics, pharmacodynamics, and preliminary clinical efficacy will also be assessed.

Who can take part

Age range
18 Years to 65 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 1
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

18 locations listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.